Sex Differences in Depression and Anxiety
- PMID: 35915385
- DOI: 10.1007/7854_2022_375
Sex Differences in Depression and Anxiety
Abstract
Depression and anxiety disorders carry a tremendous worldwide burden and emerge as a significant cause of disability among western societies. Both disorders are known to disproportionally affect women, as they are twice more likely to be diagnosed and moreover, they are also prone to suffer from female-specific mood disorders. Importantly, the prevalence of these affective disorders has notably risen after the COVID pandemic, especially in women. In this chapter, we describe factors that are possibly contributing to the expression of such sex differences in depression and anxiety. For this, we overview the effect of transcriptomic and genetic factors, the immune system, neuroendocrine aspects, and cognition. Furthermore, we also provide evidence of sex differences in antidepressant response and their causes. Finally, we emphasize the importance to consider sex as a biological variable in preclinical and clinical research, which may facilitate the discovery and development of new and more efficacious antidepressant and anxiolytic pharmacotherapies for both women and men.
Keywords: Antidepressants; Anxiety; Depression; Sex differences; Stress.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Preclinical sex differences in depression and antidepressant response: Implications for clinical research.J Neurosci Res. 2017 Jan 2;95(1-2):731-736. doi: 10.1002/jnr.23861. J Neurosci Res. 2017. PMID: 27870451 Review.
-
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005. CNS Drugs. 2008. PMID: 18840035
-
Changes in antidepressant use in Australia: A nationwide analysis (2015-2021).Aust N Z J Psychiatry. 2023 Jan;57(1):49-57. doi: 10.1177/00048674221079740. Epub 2022 Feb 17. Aust N Z J Psychiatry. 2023. PMID: 35176912
-
Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.Aust N Z J Psychiatry. 2010 Jun;44(6):513-9. doi: 10.3109/00048670903555138. Aust N Z J Psychiatry. 2010. PMID: 20482411
-
Sex differences in depression: Insights from clinical and preclinical studies.Prog Neurobiol. 2019 May;176:86-102. doi: 10.1016/j.pneurobio.2019.01.006. Epub 2019 Feb 2. Prog Neurobiol. 2019. PMID: 30721749 Review.
Cited by
-
Mental health across two years of the COVID-19 pandemic: a 5-wave longitudinal study in Germany.Front Psychiatry. 2023 Aug 8;14:1229700. doi: 10.3389/fpsyt.2023.1229700. eCollection 2023. Front Psychiatry. 2023. PMID: 37614651 Free PMC article.
-
The silent struggle: assessing anxiety prevalence in Marrakech's hypertensive population.BMC Public Health. 2025 Mar 28;25(1):1179. doi: 10.1186/s12889-025-22459-z. BMC Public Health. 2025. PMID: 40155918 Free PMC article.
-
The Interaction of Vasopressin with Hormones of the Hypothalamo-Pituitary-Adrenal Axis: The Significance for Therapeutic Strategies in Cardiovascular and Metabolic Diseases.Int J Mol Sci. 2024 Jul 5;25(13):7394. doi: 10.3390/ijms25137394. Int J Mol Sci. 2024. PMID: 39000501 Free PMC article. Review.
-
Effects of Sex and Race on Epidemiology and Comorbidities of Patients with Irritable Bowel Syndrome: A Rome III Era Retrospective Study.Diseases. 2025 May 21;13(5):161. doi: 10.3390/diseases13050161. Diseases. 2025. PMID: 40422593 Free PMC article.
-
Sex Differences in Stress Response: Classical Mechanisms and Beyond.Curr Neuropharmacol. 2024;22(3):475-494. doi: 10.2174/1570159X22666231005090134. Curr Neuropharmacol. 2024. PMID: 37855285 Free PMC article.
References
-
- Agid Y, Buzsáki G, Diamond DM, Frackowiak R, Giedd J, Girault JA, Grace A, Lambert JJ, Manji H, Mayberg H, Popoli M, Prochiantz A, Richter-Levin G, Somogyi P, Spedding M, Svenningsson P, Weinberger D (2007) How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 6:189–201 - PubMed
-
- Alexander A, Irving AJ, Harvey J (2017) Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS. Neuropharmacology 113:652–660 - PubMed
-
- Amsterdam J, Garcia-España F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, Beasley C (1999) Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 55:11–17 - PubMed
-
- Anderson GD (2005) Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 14(1):19–29 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical